Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BONMOT: Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia
NCT00434616Phase 3Unknown
- Sponsor
- Franziskus-Krankenhaus Berlin
- Start
- Apr 2007
- Primary completion
- Apr 2011
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of autologous bone marrow-derived mononuclear cell in critical limb ischemia (CLI), sponsored by Franziskus-Krankenhaus Berlin. Status: unknown.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT00434616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434616.